These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

679 related items for PubMed ID: 29144805

  • 1. DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
    Ferjan S, Janez A, Jensterle M.
    Endocr Pract; 2018 Jan; 24(1):69-77. PubMed ID: 29144805
    [Abstract] [Full Text] [Related]

  • 2. SHORT-TERM SITAGLIPTIN-METFORMIN THERAPY IS MORE EFFECTIVE THAN METFORMIN OR PLACEBO IN PRIOR GESTATIONAL DIABETIC WOMEN WITH IMPAIRED GLUCOSE REGULATION.
    Elkind-Hirsch KE, Paterson MS, Shaler D, Gutowski HC.
    Endocr Pract; 2018 Apr; 24(4):361-368. PubMed ID: 29561188
    [Abstract] [Full Text] [Related]

  • 3. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.
    Ferjan S, Janez A, Jensterle M.
    Metab Syndr Relat Disord; 2017 Dec; 15(10):515-520. PubMed ID: 29064743
    [Abstract] [Full Text] [Related]

  • 4. Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved β-cell function and insulin sensitivity in metformin treated PCOS.
    Jensterle M, Goricar K, Janez A.
    Endocr Res; 2017 Nov; 42(4):261-268. PubMed ID: 28323503
    [Abstract] [Full Text] [Related]

  • 5. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
    Stovall DW, Bailey AP, Pastore LM.
    J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
    [Abstract] [Full Text] [Related]

  • 6. Sitagliptin Decreases Visceral Fat and Blood Glucose in Women With Polycystic Ovarian Syndrome.
    Devin JK, Nian H, Celedonio JE, Wright P, Brown NJ.
    J Clin Endocrinol Metab; 2020 Jan 01; 105(1):136-51. PubMed ID: 31529097
    [Abstract] [Full Text] [Related]

  • 7. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
    Elkind-Hirsch KE, Paterson MS, Seidemann EL, Gutowski HC.
    Fertil Steril; 2017 Jan 01; 107(1):253-260.e1. PubMed ID: 28228317
    [Abstract] [Full Text] [Related]

  • 8. Effects of saxagliptin on glucose homeostasis and body composition of obese patients with newly diagnosed pre-diabetes.
    Wang Z, Xu D, Huang L, Zhang T, Wang J, Chen Q, Kong L, Zhou X.
    Diabetes Res Clin Pract; 2017 Aug 01; 130():77-85. PubMed ID: 28575729
    [Abstract] [Full Text] [Related]

  • 9. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
    Song DK, Hong YS, Sung YA, Lee H.
    PLoS One; 2017 Aug 01; 12(5):e0178120. PubMed ID: 28542421
    [Abstract] [Full Text] [Related]

  • 10. Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance.
    Kelly A, Sheikh S, Stefanovski D, Peleckis AJ, Nyirjesy SC, Eiel JN, Sidhaye A, Localio R, Gallop R, De Leon DD, Hadjiliadis D, Rubenstein RC, Rickels MR.
    J Clin Endocrinol Metab; 2021 Aug 18; 106(9):2617-2634. PubMed ID: 34406395
    [Abstract] [Full Text] [Related]

  • 11. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
    Zhang J, Xing C, Cheng X, He B.
    Front Endocrinol (Lausanne); 2022 Aug 18; 13():1003238. PubMed ID: 36147577
    [Abstract] [Full Text] [Related]

  • 12. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U, Pall M, Mathur R, Azziz R.
    Hum Reprod; 2014 Jul 18; 29(7):1508-17. PubMed ID: 24813197
    [Abstract] [Full Text] [Related]

  • 13. Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes.
    Otsuka Y, Yamaguchi S, Furukawa A, Kosuda M, Nakazaki M, Ishihara H.
    Endocr J; 2015 Jul 18; 62(2):133-43. PubMed ID: 25328079
    [Abstract] [Full Text] [Related]

  • 14. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May 18; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA, Lewy V, Danadian K, Saad R.
    J Clin Endocrinol Metab; 2002 Apr 18; 87(4):1555-9. PubMed ID: 11932281
    [Abstract] [Full Text] [Related]

  • 17. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov 18; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 18. Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis.
    Sharma ST, Wickham EP, Nestler JE.
    Endocr Pract; 2007 Nov 18; 13(4):373-9. PubMed ID: 17669713
    [Abstract] [Full Text] [Related]

  • 19. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M, Yang M, Zhou X, Fang X, Hu W, Zhu W, Wang C, Liu D, Li S, Liu H, Yang G, Li L.
    J Clin Endocrinol Metab; 2015 Apr 18; 100(4):1485-93. PubMed ID: 25675380
    [Abstract] [Full Text] [Related]

  • 20. Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome.
    Savastano S, Valentino R, Pizza G, De Rosa A, Orio F, Passaretti F, Formisano P, Lombardi G, Beguinot F, Colao A.
    J Endocrinol Invest; 2010 Apr 18; 33(7):446-50. PubMed ID: 20671408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.